A Randomized, Crossover, Placebo Controlled, Double-blind Trial of the Effect of STIOLTO RESPIMAT on Central and Peripheral Components of Fatigue During Exercise in Chronic Obstructive Pulmonary Disease
Phase of Trial: Phase IV
Latest Information Update: 23 Aug 2017
At a glance
- Drugs Olodaterol/tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease; Fatigue
- Focus Therapeutic Use
- 16 Aug 2017 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 16 Aug 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Jul 2018.
- 16 Aug 2017 Status changed from not yet recruiting to recruiting.